Livongo health, inc. (LVGO)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Dec'18
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value

218,228

241,738

349,820

38,165

108,928

Short-term investments

150,000

150,000

50,000

-

0

Accounts receivable, net of allowance for doubtful accounts of $1,385 and $1,245 as of March 31, 2020 and December 31, 2019, respectively

52,446

40,875

40,901

35,086

16,623

Inventories

19,245

28,983

21,274

13,835

8,934

Deferred costs and other, current

22,595

16,051

12,223

10,969

6,022

Prepaid Expense and Other Assets, Current

13,869

9,860

9,350

5,718

4,935

Total current assets

476,383

487,507

483,568

103,773

145,442

Property and equipment, net

12,835

10,354

8,975

7,564

5,837

Operating lease right-of-use assets

17,189

-

-

-

-

Restricted Cash, Noncurrent

1,270

1,270

1,270

858

200

Goodwill

35,800

35,801

35,794

35,794

15,709

Finite-Lived Intangible Assets, Net

15,773

16,469

17,165

17,861

5,154

Deferred costs and other, noncurrent

10,495

5,700

4,586

4,947

2,447

Other Assets, Noncurrent

215

3,460

3,547

6,412

5,485

TOTAL ASSETS

569,961

560,561

554,905

177,209

180,253

LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

8,509

8,362

7,636

8,975

6,377

Accrued Liabilities, Current

29,068

27,801

28,803

24,318

16,152

Deferred revenue, current

5,351

3,945

3,909

3,467

1,614

Advance payments from partner, current

1,767

1,767

1,767

1,343

293

Total current liabilities

44,695

41,875

42,115

38,103

24,436

Operating lease liabilities, noncurrent

15,476

-

-

-

-

Deferred revenue, noncurrent

748

654

670

637

437

Advance payment from partner, noncurrent

7,754

7,754

7,754

7,754

6,432

Other noncurrent liabilities

0

2,914

3,040

3,173

3,825

TOTAL LIABILITIES

68,673

53,197

53,579

49,667

35,130

Redeemable convertible preferred stock, par value of $0.001 per share; zero and 58,615 shares authorized, issued and outstanding as of December 31, 2019 and 2018, respectively; aggregate liquidation preference of zero and $237,650 as of December 31, 2019 and 2018, respectively

-

-

0

237,012

236,929

Stockholders’ equity:
Preferred stock, par value of $0.001 per share; 100,000 shares authorized as of March 31, 2020 and December 31, 2019, respectively; zero shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

0

0

0

-

0

Common stock, par value of $0.001 per share; 900,000 shares authorized as of March 31, 2020 and December 31, 2019, respectively; 97,293 and 95,301 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively

97

95

94

21

18

Additional paid-in capital

670,962

671,467

663,761

33,326

21,789

Accumulated deficit

-169,800

-164,198

-162,529

-142,817

-113,613

Stockholders' Equity Attributable to Parent

501,288

507,364

501,326

-109,470

-91,806

TOTAL LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS’ EQUITY

569,961

560,561

554,905

177,209

180,253